Assessing liver function by liver enhancement during the hepatobiliary phase with Gd-EOB-DTPA-enhanced MRI at 3 Tesla

[1]  P. Wiggermann,et al.  Impact of liver cirrhosis on liver enhancement at Gd-EOB-DTPA enhanced MRI at 3 Tesla. , 2013, European journal of radiology.

[2]  Julien Vergniol,et al.  Liver fibrosis: noninvasive assessment with acoustic radiation force impulse elastography--comparison with FibroScan M and XL probes and FibroTest in patients with chronic liver disease. , 2013, Radiology.

[3]  K. Frey,et al.  Predictive models for regional hepatic function based on 99mTc-IDA SPECT and local radiation dose for physiologic adaptive radiation therapy. , 2013, International journal of radiation oncology, biology, physics.

[4]  B. Hamm,et al.  Increase in left liver lobe function after preoperative right portal vein embolisation assessed with gadolinium-EOB-DTPA MRI , 2013, European Radiology.

[5]  O. Matsui,et al.  Relationship between signal intensity on hepatobiliary phase of gadolinium ethoxybenzyl diethylenetriaminepentaacetic acid (Gd-EOB-DTPA)-enhanced MR imaging and prognosis of borderline lesions of hepatocellular carcinoma. , 2012, European journal of radiology.

[6]  H. Honda,et al.  MR prediction of liver fibrosis using a liver‐specific contrast agent: Superparamagnetic iron oxide versus Gd‐EOB‐DTPA , 2012, Journal of magnetic resonance imaging : JMRI.

[7]  Y. Chawla,et al.  Indocyanine green clearance test (using spectrophotometry) and its correlation with model for end stage liver disease (MELD) score in Indian patients with cirrhosis of liver. , 2012, Tropical gastroenterology : official journal of the Digestive Diseases Foundation.

[8]  H. Hussain,et al.  Primovist, Eovist: what to expect? , 2012, Journal of hepatology.

[9]  Ioan Sporea,et al.  Intra- and interoperator reproducibility of acoustic radiation force impulse (ARFI) elastography--preliminary results. , 2012, Ultrasound in medicine & biology.

[10]  M. Botelho,et al.  Study of perioperative liver function by dynamic monitoring of ICG-clearance. , 2012, Hepato-gastroenterology.

[11]  坪山 尚寛.  Hepatocellular carcinoma : hepatocyte-selective enhancement at gadoxetic acid-enhanced MR imaging : correlation with expression of sinusoidal and canalicular transporters and bile accumulation , 2012 .

[12]  P. Sandström,et al.  Quantifying differences in hepatic uptake of the liver specific contrast agents Gd-EOB-DTPA and Gd-BOPTA: a pilot study , 2012, European Radiology.

[13]  T. Sone,et al.  Gd-EOB-DTPA-enhanced MR imaging: evaluation of hepatic enhancement effects in normal and cirrhotic livers. , 2011, European journal of radiology.

[14]  S. Cho,et al.  The value of gadoxetate disodium-enhanced MR imaging for predicting posthepatectomy liver failure after major hepatic resection: a preliminary study. , 2011, European journal of radiology.

[15]  V. Chernyak,et al.  Hepatic enhancement during the hepatobiliary phase after gadoxetate disodium administration in patients with chronic liver disease: The role of laboratory factors , 2011, Journal of magnetic resonance imaging : JMRI.

[16]  S. Kumano,et al.  Estimation of Liver Function Using T1 Mapping on Gd-EOB-DTPA-Enhanced Magnetic Resonance Imaging , 2011, Investigative radiology.

[17]  Osamu Matsui,et al.  Cirrhotic rat liver: reference to transporter activity and morphologic changes in bile canaliculi--gadoxetic acid-enhanced MR imaging. , 2010, Radiology.

[18]  M. Schwartz,et al.  Liver Functional Reserve Estimation: State of the Art and Relevance to Local Treatments , 2010, Oncology.

[19]  K. Ohtomo,et al.  Relationship Between Liver Function and Liver Signal Intensity in Hepatobiliary Phase of Gadolinium Ethoxybenzyl Diethylenetriamine Pentaacetic Acid-Enhanced Magnetic Resonance Imaging , 2010, Journal of computer assisted tomography.

[20]  U. Motosugi,et al.  Liver parenchymal enhancement of hepatocyte‐phase images in Gd‐EOB‐DTPA‐enhanced MR imaging: Which biological markers of the liver function affect the enhancement? , 2009, Journal of magnetic resonance imaging : JMRI.

[21]  T. Murakami,et al.  Potential of Gadolinium-ethoxybenzyl-diethylenetriamine Pentaacetic Acid (Gd-EOB-DTPA) for Differential Diagnosis of Nonalcoholic Steatohepatitis and Fatty Liver in Rats Using Magnetic Resonance Imaging , 2007, Investigative radiology.

[22]  W. Kim,et al.  The model for end‐stage liver disease (MELD) , 2007, Hepatology.

[23]  D. Sahani,et al.  Efficacy and safety of MR imaging with liver-specific contrast agent: U.S. multicenter phase III study. , 2005, Radiology.

[24]  F. Terrier,et al.  Magnetic Resonance Imaging With Hepatospecific Contrast Agents in Cirrhotic Rat Livers , 2005, Investigative radiology.

[25]  Yongmin Chang,et al.  Quantitative Evaluation of Liver Function with MRI Using Gd-EOB-DTPA , 2004, Korean journal of radiology.

[26]  C. Gartung,et al.  Effects of proinflammatory cytokines on rat organic anion transporters during toxic liver injury and cholestasis , 2003, Hepatology.

[27]  F. Lammert,et al.  Hepatobiliary organic anion transporters are differentially regulated in acute toxic liver injury induced by carbon tetrachloride. , 2002, Journal of hepatology.

[28]  H. Maeta,et al.  Evaluation of liver function for the application of preoperative portal vein embolization on major hepatic resection. , 2002, Hepato-gastroenterology.

[29]  P. Meier,et al.  Hepatic uptake of the magnetic resonance imaging contrast agent gadoxetate by the organic anion transporting polypeptide Oatp1. , 1999, The Journal of pharmacology and experimental therapeutics.

[30]  F Uggeri,et al.  Molecular mechanisms for the hepatic uptake of magnetic resonance imaging contrast agents. , 1999, Biochemical and biophysical research communications.

[31]  T. Frenzel,et al.  Mechanism of hepatic uptake of gadoxetate disodium. , 1996, Academic radiology.

[32]  M. Taupitz,et al.  Phase I clinical evaluation of Gd-EOB-DTPA as a hepatobiliary MR contrast agent: safety, pharmacokinetics, and MR imaging. , 1995, Radiology.

[33]  H. Weinmann,et al.  Elimination of Gadolinium‐Ethoxybenzyl-DTPA in a Rat Model of Severely Impaired Liver and Kidney Excretory Function, An Experimental Study in Rats , 1994, Investigative radiology.

[34]  H. Weinmann,et al.  A new lipophilic gadolinium chelate as a tissue‐specific contrast medium for MRI , 1991, Magnetic resonance in medicine.

[35]  B. Maharaj,et al.  SAMPLING VARIABILITY AND ITS INFLUENCE ON THE DIAGNOSTIC YIELD OF PERCUTANEOUS NEEDLE BIOPSY OF THE LIVER , 1986, The Lancet.

[36]  H. Popper.  Pathologic aspects of cirrhosis. A review. , 1977, The American journal of pathology.

[37]  Plumley Pf.  Letter: the consultants' contract. , 1975, Lancet.

[38]  H. Popper,et al.  Pathologic aspects of cirrhosis. , 1958, The American journal of medicine.

[39]  J. Ledsam,et al.  Measuring hepatic functional reserve using low temporal resolution Gd-EOB-DTPA dynamic contrast-enhanced MRI: a preliminary study comparing galactosyl human serum albumin scintigraphy with indocyanine green retention , 2013, European Radiology.

[40]  J. Kao,et al.  Dynamic contrast-enhanced magnetic resonance imaging with Gd-EOB-DTPA for the evaluation of liver fibrosis in chronic hepatitis patients , 2011, European Radiology.

[41]  R. Wiesner,et al.  Model for end-stage liver disease (MELD) and allocation of donor livers. , 2003, Gastroenterology.